Relmada Therapeutics (RLMD) Return on Assets (2013 - 2026)
Relmada Therapeutics (RLMD) reported Return on Assets of 0.0% for Q1 2026, up 2.0% year-over-year from 0.0% in Q1 2025, and up 66.53% on a QoQ basis from 0.01% in Q4 2025.
Relmada Therapeutics (RLMD) has 14 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Assets rose 2.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 2.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets climbed to 0.0% in Q1 2026 per RLMD's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.03% in Q3 2025.
- The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
- The widest annual swing landed in 2025, when Return on Assets slipped 2 bps; it then grew 2 bps in 2026.
- Tracing RLMD's Return on Assets over 5 years: stood at 0.01% in 2022, then dropped by 1 bps to 0.01% in 2023, then plunged by 66 bps to 0.02% in 2024, then soared by 33 bps to 0.01% in 2025, then jumped by 67 bps to 0.0% in 2026.
- Per Business Quant, the three latest RLMD Return on Assets figures stand at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.03% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.02% |
| Mar 31, 2019 | -0.03% |
| Dec 31, 2018 | -0.04% |
| Sep 30, 2018 | -0.03% |
| Jun 30, 2018 | -0.01% |
| Mar 31, 2018 | -0.01% |
| Dec 31, 2017 | -0.01% |
| Sep 30, 2017 | -0.02% |
| Jun 30, 2017 | -0.02% |
| Mar 31, 2017 | -0.02% |
| Dec 31, 2016 | -0.01% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.01% |
| Mar 31, 2016 | -0.01% |
| Dec 31, 2015 | -0.01% |
| Sep 30, 2015 | -0.01% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.01% |
| Dec 31, 2014 | -0.01% |
| Sep 30, 2014 | -0.01% |
| Nov 30, 2013 | -0.02% |
| Aug 31, 2013 | -0.03% |
| May 31, 2013 | -0.06% |